Moreover, the SELECT study showed that semaglutide significantly reduced the incidence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke (hazard ratio 0.80) ( 6 Practical issues when prescribing GLP-1RA in T1D GLP-1RA are not currently approved for treatment of T1D, but they may still be covered by insurance if prescribed to treat obesity in these patients (although insurance coverage for obesity remains limited)
Mao D, Cao H, Shi M, Wang CC, Kwong J, Li JJ, et al
We performed meta-analysis using a random-effects model to calculate risk ratios (RRs) and 95% confidence intervals (CIs)
The new drug is in its early trial stage before being cleared for use
Whether these appetite-lowering effects of thylakoids could be a useful strategy in controlling obesity in the long term is still ambiguous
Marks SJ, Moore NR, Ryley NG, Clark ML, Pointon JJ, Strauss BJ, et al